Phase 1a/1b First-in-Human Study of BG-C9074 Alone and in Combination With Other Anticancer Therapies in Patients With Advanced Solid Tumors
Clinical trial NCT06233942 · RECRUITING
Trial details
- NCT number
- NCT06233942
- Sponsor
- BeOne Medicines
- Status
- RECRUITING
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2024-04-12
- Primary completion
- 2027-09-28
- Enrollment
- 308
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.